• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
30-day Readmission After an Acute Exacerbation of Chronic Obstructive Pulmonary Disease is Associated with Cardiovascular Comorbidity.慢性阻塞性肺疾病急性加重后30天再入院与心血管合并症相关。
Turk Thorac J. 2021 Sep;22(5):369-375. doi: 10.5152/TurkThoracJ.2021.0189.
2
Early Hospital Readmissions after an Acute Exacerbation of Chronic Obstructive Pulmonary Disease in the Nationwide Readmissions Database.在全国再入院数据库中,慢性阻塞性肺疾病急性加重后的早期医院再入院。
Ann Am Thorac Soc. 2018 Jul;15(7):837-845. doi: 10.1513/AnnalsATS.201712-913OC.
3
The impact on thirty day readmissions for patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease admitted to an observation unit versus an inpatient medical unit: A retrospective observational study.观察单元与住院内科病房收治的慢性阻塞性肺疾病急性加重患者 30 天再入院率的影响:一项回顾性观察研究。
Chron Respir Dis. 2024 Jan-Dec;21:14799731241242490. doi: 10.1177/14799731241242490.
4
Risk assessment and rate of readmission within 30 days of discharge after hospitalization for acute exacerbation of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重住院后 30 天内出院的风险评估和再入院率。
Tuberk Toraks. 2021 Sep;69(3):328-337. doi: 10.5578/tt.20219705.
5
Impact of individualized care on readmissions after a hospitalization for acute exacerbation of COPD.个体化护理对慢性阻塞性肺疾病急性加重住院后再入院的影响。
Int J Chron Obstruct Pulmon Dis. 2016 Jan 5;11:61-71. doi: 10.2147/COPD.S93322. eCollection 2016.
6
Early readmission and mortality in acute exacerbation of chronic obstructive pulmonary disease with community-acquired pneumonia.慢性阻塞性肺疾病急性加重合并社区获得性肺炎的早期再入院和死亡率。
Chron Respir Dis. 2019 Jan-Dec;16:1479972318809480. doi: 10.1177/1479972318809480.
7
Association of acute kidney injury with readmissions after hospitalization for acute exacerbation of chronic obstructive pulmonary disease: a population-based study.急性肾损伤与慢性阻塞性肺疾病急性加重住院后再入院的关系:一项基于人群的研究。
BMC Nephrol. 2020 Apr 3;21(1):116. doi: 10.1186/s12882-020-01780-2.
8
Hospitalization with acute exacerbation of chronic obstructive pulmonary disease and associated health resource utilization: a population-based Danish cohort study.慢性阻塞性肺疾病急性加重住院治疗及相关卫生资源利用:基于人群的丹麦队列研究。
J Med Econ. 2013 Jul;16(7):897-906. doi: 10.3111/13696998.2013.800525. Epub 2013 May 23.
9
PD-1 T lymphocyte proportions and hospitalized exacerbation of COPD: a prospective cohort study.PD-1 阳性 T 淋巴细胞比例与 COPD 住院加重的相关性:一项前瞻性队列研究。
Respir Res. 2024 May 24;25(1):218. doi: 10.1186/s12931-024-02847-6.
10
Outcomes associated with acute exacerbations of chronic obstructive pulmonary disorder requiring hospitalization.与需要住院治疗的慢性阻塞性肺疾病急性加重相关的结局
Lung India. 2015 Sep-Oct;32(5):465-72. doi: 10.4103/0970-2113.164150.

引用本文的文献

1
A systematic review and meta-analysis of chronic obstructive pulmonary disease in asia: risk factors for readmission and readmission rate.亚洲慢性阻塞性肺疾病的系统评价和荟萃分析:再入院的危险因素和再入院率。
BMC Pulm Med. 2024 Aug 12;24(1):388. doi: 10.1186/s12890-024-03203-6.
2
Predictors of Readmission, for Patients with Chronic Obstructive Pulmonary Disease (COPD) - A Systematic Review.慢性阻塞性肺疾病(COPD)患者再入院的预测因素——一项系统综述
Int J Chron Obstruct Pulmon Dis. 2023 Nov 18;18:2581-2617. doi: 10.2147/COPD.S418295. eCollection 2023.

本文引用的文献

1
Risk factors for all-cause hospital readmission following exacerbation of COPD: a systematic review and meta-analysis.慢性阻塞性肺疾病恶化后全因住院再入院的危险因素:系统评价和荟萃分析。
Eur Respir Rev. 2020 Jun 3;29(156). doi: 10.1183/16000617.0166-2019. Print 2020 Jun 30.
2
Factors Associated with Differential Readmission Diagnoses Following Acute Exacerbations of Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病急性加重后不同再入院诊断的相关因素
J Hosp Med. 2020 Apr 1;15(4):219-227. doi: 10.12788/jhm.3367. Epub 2020 Feb 11.
3
Reducing Chronic Obstructive Pulmonary Disease Hospital Readmissions. An Official American Thoracic Society Workshop Report.降低慢性阻塞性肺疾病的住院再入院率。美国胸科学会官方专题研讨会报告。
Ann Am Thorac Soc. 2019 Feb;16(2):161-170. doi: 10.1513/AnnalsATS.201811-755WS.
4
Association of the Hospital Readmissions Reduction Program With Mortality Among Medicare Beneficiaries Hospitalized for Heart Failure, Acute Myocardial Infarction, and Pneumonia.医院再入院率降低计划与医疗保险受益人因心力衰竭、急性心肌梗死和肺炎住院的死亡率之间的关联。
JAMA. 2018 Dec 25;320(24):2542-2552. doi: 10.1001/jama.2018.19232.
5
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、地区和国家残疾调整生命年(DALYs)359 种疾病和伤害以及 195 个国家和地区 1990-2017 年的健康期望寿命(HALE):2017 年全球疾病负担研究的系统分析。
Lancet. 2018 Nov 10;392(10159):1859-1922. doi: 10.1016/S0140-6736(18)32335-3.
6
Role of Comorbidities in Treatment and Outcomes after Chronic Obstructive Pulmonary Disease Exacerbations.合并症在慢性阻塞性肺疾病加重后的治疗和结局中的作用。
Ann Am Thorac Soc. 2018 Sep;15(9):1033-1038. doi: 10.1513/AnnalsATS.201804-255OC.
7
Does eosinophilia and neutrophil to lymphocyte ratio affect hospital re-admission in cases of COPD exacerbation?嗜酸性粒细胞增多和中性粒细胞与淋巴细胞比值是否会影响慢性阻塞性肺疾病急性加重患者的再次入院情况?
Tuberk Toraks. 2017 Dec;65(4):282-290. doi: 10.5578/tt.57278.
8
Early Hospital Readmissions after an Acute Exacerbation of Chronic Obstructive Pulmonary Disease in the Nationwide Readmissions Database.在全国再入院数据库中,慢性阻塞性肺疾病急性加重后的早期医院再入院。
Ann Am Thorac Soc. 2018 Jul;15(7):837-845. doi: 10.1513/AnnalsATS.201712-913OC.
9
Exacerbations of COPD.COPD 恶化。
Eur Respir Rev. 2018 Mar 14;27(147). doi: 10.1183/16000617.0103-2017. Print 2018 Mar 31.
10
Trends in 30-day readmission rates after COPD hospitalization, 2006-2012.慢性阻塞性肺疾病(COPD)住院后 30 天再入院率的趋势,2006-2012 年。
Respir Med. 2017 Sep;130:92-97. doi: 10.1016/j.rmed.2017.07.058. Epub 2017 Jul 26.

慢性阻塞性肺疾病急性加重后30天再入院与心血管合并症相关。

30-day Readmission After an Acute Exacerbation of Chronic Obstructive Pulmonary Disease is Associated with Cardiovascular Comorbidity.

作者信息

Ozgen Alpaydin Aylin, Ozuygur Saliha Selin, Sahan Ceyda, Tertemiz Kemal Can, Russell Richard

机构信息

Department of Pulmonary Diseases, Dkuz Eylül University, Faculty of Medicine, İzmir, Turkey.

Department of Public Health, Hacettepe University, Faculty of Medicine, Ankara, Turkey.

出版信息

Turk Thorac J. 2021 Sep;22(5):369-375. doi: 10.5152/TurkThoracJ.2021.0189.

DOI:10.5152/TurkThoracJ.2021.0189
PMID:35110209
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8975363/
Abstract

OBJECTIVE

Readmission after hospitalization for a chronic disease is a major concern of interest for health care quality. Our aim was to investigate the predictors and rates of early readmission after an acute exacerbation of chronic obstructive pulmonary disease (AECOPD) in a tertiary care hospital.

MATERIAL AND METHODS

Over a 3-year period, patients hospitalized in our pulmonary disease clinic with a diagnosis of chronic obstructive pulmonary disease (COPD) and who had an index hospitalization for AECOPD were included. Readmission was defined as rehospitalization within 30 days of AECOPD discharge. Demographics, comorbidities, exacerbations, prior intensive care unit (ICU) stay, and long-term oxygen therapy (LTOT), blood eosinophil count, and antibiotic and/or steroid treatment at the index AECOPD admission were recorded.

RESULTS

Fifty-two (17.3%) readmissions occurred in 300 patients. Readmissions were due to AECOPD in 46.2%, pneumonia in 19.2%, and cardiovascular disease in 15.4% patients. Twenty-one (40%) of the readmitted patients were frequent exacerbators. After adjusting for individual and clinical predictors, the odds ratio for readmission was 2.11 (95% CI, 1.07-4.15, P = .03) for those with congestive heart failure, 3.30 (95% CI, 1.05-9.75, P = .04) for those with arrhythmia, and 1.99 (95% CI, 1.04-3.81, P = .04) for LTOT users prior to AECOPD.

CONCLUSION

A significant majority of patients readmitted after an AECOPD mainly suffered from recurrent AECOPD. Associated congestive heart failure, arrhythmia, and prior LTOT were risk factors identified for early AECOPD readmissions in our study. Better recognition of readmission risk factors might help to reduce readmission rates of AECOPD.

摘要

目的

慢性病住院后的再入院是医疗质量关注的一个主要问题。我们的目的是调查三级医院中慢性阻塞性肺疾病急性加重(AECOPD)后早期再入院的预测因素和发生率。

材料与方法

在3年期间,纳入我院肺病门诊诊断为慢性阻塞性肺疾病(COPD)且因AECOPD进行首次住院治疗的患者。再入院定义为AECOPD出院后30天内再次住院。记录患者的人口统计学资料、合并症、病情加重情况、既往重症监护病房(ICU)住院史、长期氧疗(LTOT)、血液嗜酸性粒细胞计数以及首次AECOPD入院时的抗生素和/或类固醇治疗情况。

结果

300例患者中有52例(17.3%)再次入院。再入院原因中,46.2%是由于AECOPD,19.2%是肺炎,15.4%是心血管疾病。21例(40%)再入院患者是频繁病情加重者。在对个体和临床预测因素进行校正后,充血性心力衰竭患者再入院的比值比为2.11(95%可信区间,1.07 - 4.15,P = 0.03),心律失常患者为3.30(95%可信区间,1.05 - 9.75,P = 0.04),AECOPD之前使用LTOT的患者为1.99(95%可信区间,1.04 - 3.81,P = 0.04)。

结论

AECOPD后再入院的患者中,绝大多数主要患有复发性AECOPD。在我们的研究中,相关的充血性心力衰竭、心律失常以及既往LTOT是AECOPD早期再入院的危险因素。更好地识别再入院危险因素可能有助于降低AECOPD的再入院率。